# Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma

> **NCT01102608** · PHASE2 · COMPLETED · sponsor: **Grupo Espanol de Investigacion en Sarcomas** · enrollment: 32 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Ifosfamide

## Key facts

- **NCT ID:** NCT01102608
- **Lead sponsor:** Grupo Espanol de Investigacion en Sarcomas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102608, "Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01102608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*